Search Results
Sep 29, 2025, 15:08 ET More Ways to Sip Healthy: Javvy Coffee Expands Its Sprouts Selection with Collagen Creamer and Concentrates
coffee drinks, hot or cold, without the hassle. Simply add 1–2 teaspoons to water or milk, and you're ready to enjoy a premium coffee experience with 80mg of caffeine. Made with 100% real coffee, no sugar, no chemicals, and better-for-you ingredients, it's a convenient, better-for-you
More news about: Javvy Coffee
Sep 29, 2025, 14:17 ET Fusion CBD Products' Wiggles and Paws Could Help Dogs, Cats, and Horses
that investigated the usefulness of treating dogs with CBD to alleviate the stress of car travel. It found that treating dogs once a day orally with 4 mg/kg of CBD led to decreased cortisol levels, less whining, and less lip licking – all signs of stress in dogs. Dogs treated with the same amount of CBD
More news about: Fusion CBD Products
Sep 29, 2025, 08:00 ET PureHealth Research Launches New Ashwagandha Supplement to Combat Modern Stress
Ashwagandha supplement features a premium-grade, whole-root Ashwagandha extract in a potent 600mg daily serving . It is carefully formulated to deliver a range of tangible health benefits:
More news about: PureHealth Research
Sep 29, 2025, 08:00 ET U.S. FDA approves TREMFYA® (guselkumab) for the treatment of pediatric plaque psoriasis and active psoriatic arthritis, marking a first and only approval for an IL-23 inhibitor
Dosage Forms and Strengths: TREMFYA® is available as 100 mg/mL and 200 mg/2mL for subcutaneous injection and as a 200 mg/20 mL (10 mg/mL) single dose vial for intravenous infusion. ABOUT JOHNSON & JOHNSONAt
More news about: Johnson & Johnson
Sep 29, 2025, 07:00 ET Kedrion Biopharma Receives FDA Approval for QIVIGY® (Immune Globulin 10% IV) for treatment of Primary Humoral Immunodeficiency in Adults and confirms its plan to increase investments in the U.S. throughout its global operations.
patients with primary humoral immunodeficiency (NCT03961009). A total of 47 patients received intravenous infusion of QIVIGY at the dose of 266 to 826 mg/kg every 3 or 4 weeks for 12 months. Thirty-nine and 8 patients were administered QIVIGY on a 4-week or a 3-week infusion cycle, respectively.
More news about: Kedrion Biopharma
Sep 29, 2025, 06:00 ET AllRock Bio Presents Phase 1 Data for Lead Program, ROC-101, at the ERS Congress
Strong safety and tolerability: ROC-101 was safe and well-tolerated at all doses tested, up to 40 mg once daily. The study found no evidence of hypotension at any dose.Among those receiving ROC-101, the most common treatment emergent
More news about: AllRock Bio
Sep 29, 2025, 02:38 ET Leqembi® approved for IV maintenance treatment in China
as early AD) in China. After 18 months of a dosing regimen of 10 mg/kg once every two weeks during initiation phase, a transition to the maintenance dosing regimen of 10 mg/kg once every four weeks may be considered or the regimen of 10 mg/kg once every two weeks may be continued. AD
More news about: BioArctic
Sep 29, 2025, 02:34 ET Leqembi® approved for IV maintenance treatment in China
as early AD) in China. After 18 months of a dosing regimen of 10 mg/kg once every two weeks during initiation phase, a transition to the maintenance dosing regimen of 10 mg/kg once every four weeks may be considered or the regimen of 10 mg/kg once every two weeks may be continued. AD
More news about: BioArctic
Sep 28, 2025, 10:00 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed
More news about: Pomerantz LLP
Sep 26, 2025, 11:42 ET Desert Harvest Launches 1st Human-Identical Lactoferrin for Menopause
in menopause and beyond. Targeted Menopause Support with Clinically Proven Aloe The new Desert Harvest supplement combines 300 mg of effera™ with its proprietary Super Strength Aloe Vera, used for decades to soothe mucosal tissue and aid nutrient absorption.
More news about: Desert Harvest
Sep 26, 2025, 08:45 ET AbbVie Submits New Drug Application to U.S. FDA for Tavapadon for the Treatment of Parkinson's Disease
randomized, placebo-controlled, parallel-group, 27-week trial to evaluate the efficacy, safety and tolerability of flexible doses of tavapadon (5-15 mg QD) in early Parkinson's disease. The primary endpoint was the change from baseline in the MDS-UPDRS Parts II and III combined score. Key secondary endpoints
More news about: AbbVie
Sep 26, 2025, 08:00 ET New Data Presented on Givinostat for Treatment of Duchenne Muscular Dystrophy at 2025 Neuromuscular Study Group Annual Scientific Meeting
Monitor triglycerides at 1 month, 3 months, 6 months, and then every 6 months thereafter. Modify the dosage if fasting triglycerides are verified >300 mg/dL. Treatment with DUVYZAT should be discontinued if triglycerides remain elevated despite adequate dietary intervention and dosage adjustment. Gastrointestinal Disturbances:
More news about: ITF Therapeutics LLC
Sep 26, 2025, 02:30 ET CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
randomized, multicenter, double-blind, parallel-arm, active-controlled clinical trial evaluating the safety and efficacy of 400 mg of FILSPARI (sparsentan), compared to 300 mg of irbesartan, in 404 patients ages 18 years and up with IgAN and persistent proteinuria despite receiving at least 50% of max
More news about: Vifor International AG (CSL Vifor)
Sep 26, 2025, 02:30 ET CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
randomized, multicenter, double-blind, parallel-arm, active-controlled clinical trial evaluating the safety and efficacy of 400 mg of FILSPARI (sparsentan), compared to 300 mg of irbesartan, in 404 patients ages 18 years and up with IgAN and persistent proteinuria despite receiving at least 50% of max
More news about: Vifor International AG (CSL Vifor)
Sep 25, 2025, 14:01 ET U.S. FDA approves Inluriyo (imlunestrant) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
epidermal growth factor receptor 2-negative (HER2–) breast cancer. Inluriyo is a U.S. FDA approved oral prescription medicine, 200 mg tablets taken as a once-daily dose of 400 mg taken on an empty stomach, at least 2 hours before food or 1 hour after food. Inluriyo is also currently being studied in combination
More news about: Eli Lilly and Company
Sep 25, 2025, 12:00 ET REIGN Total Body Fuel™ Unveils Newest Ambassador DeMarcus Lawrence
defensive line mirror the ethos in every can of REIGN TBF. We're thrilled to have him join our lineup of elite ambassadors." Formulated with 300mg of natural caffeine, zero sugar, branched-chain amino acids (BCAAs), CoQ10, and electrolytes, REIGN TBF is engineered for those who demand more of themselves
More news about: REIGN Total Body Fuel
Sep 25, 2025, 10:30 ET Mint Pharmaceuticals Announces Partnership with Bayer Canada to Distribute ADALAT® XL® (nifedipine extended-release tablets) 30 mg Tablets in Canada
/PRNewswire/ - Mint Pharmaceuticals Inc. is pleased to announce a new partnership with Bayer Canada for the distribution of ADALAT® XL® 30 mg tablets
More news about: Mint Pharmaceuticals
Sep 25, 2025, 10:00 ET Tia Health and Molecular Testing Labs Partner to Launch the First-Ever FDA-Cleared Home-Collected 4-Plex STI Test
common STIs — Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), Trichomonas vaginalis (TV), and Mycoplasma genitalium (MG) — in a single collection, making it efficient, cost-effective, and comprehensive. Patients can access the test kit through an order from one of Tia's
More news about: Molecular Testing Labs
Sep 25, 2025, 08:43 ET Death Wish Coffee Co. Delivers Bold, Bottled Format with New Multi-Serve Cold Brew
bold, unsweetened Dark Roast is brewed for 18 hours to deliver rich flavor and sustainable strength. With only 10 calories and approximately 265mg of natural caffeine per serving, Death Wish Coffee Co.'s Organic Cold Brew is made with just one ingredient – coffee. Containing zero sugar, artificial
More news about: Death Wish Coffee Co.
Sep 25, 2025, 08:00 ET Vanda Pharmaceuticals announces the publication in PLOS One of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial"
demonstrating a mean improvement in latency to persistent sleep (LPS) from baseline to the average of Nights 1 and 8 of 44.9 minutes (20 mg) and 46.3 minutes (50 mg) versus 28.2 minutes (placebo) (p < 0.001). Improvements in LPS persisted through the follow-up time points (Nights 22 and 29, p < 0.01).
More news about: Vanda Pharmaceuticals Inc.
Sep 25, 2025, 08:00 ET Introducing SwimClub™: The First Clinically-Formulated Male Fertility Supplement
Statistics Reports. 2019.Safarinejad MR. Biol Trace Elem Res. 2011.Aksoy Y, et al. Andrologia. 2018.Showell MG, et al. Cochrane Database Syst Rev. 2019.Safarinejad MR. J Urol. 2009.Balercia G, et al. Fertil Steril. 2005.Boxmeer
More news about: Squared Circles
Sep 25, 2025, 07:00 ET Generate:Biomedicines to Present Phase 1 Results for AI-Engineered GB-0895 in Asthma at the European Respiratory Society International Congress
and multiple ascending dose (Part B) cohorts. Results from Part A will be presented. GB-0895 was well tolerated across a wide dose range of 10 mg to 1200 mg and demonstrated dose-proportional pharmacokinetics with a prolonged half-life of ~89 days. Sustained reductions in eosinophils, FeNO, IL-5, and
More news about: Generate:Biomedicines
Sep 25, 2025, 06:30 ET Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis
demonstrated a favorable safety and tolerability profile, with similar rates of adverse event rates compared to placebo and no new safety signals at the 45 mg once-daily dose. Overall, the CALLIPER trial data support advancing vidofludimus calcium into phase 3 studies for PMS." Late Breaking Poster
More news about: Immunic, Inc.
Sep 24, 2025, 13:18 ET Fusion CBD Products' Sleep and Recovery Softgels Could Help You Conquer Insomnia
and Recovery Softgels can help. Made from premium hemp grown in the USA, they contain 25 mg of broad spectrum hemp extract as well as 3 mg each of cannabinol and melatonin. One capsule taken 30 minutes before you hope to fall asleep may improve your sleep quality and
More news about: Fusion CBD Products